Yes, lithium and a short-term course of gabapentin can be safely taken together
Based on FDA labeling and pharmacokinetic evidence, combining lithium with gabapentin for short-term use is safe, as gabapentin does not alter lithium pharmacokinetics and the two medications have minimal drug-drug interactions. 1, 2, 3
Key Safety Evidence
No Pharmacokinetic Interaction
A controlled pharmacokinetic study specifically examined this combination and found that gabapentin at high therapeutic doses (mean 3,646 mg/day) does not cause clinically significant alterations in lithium pharmacokinetics 3. The study measured:
- Area under the curve (AUC): No significant difference
- Maximum lithium concentration (Cmax): No significant difference
- Time to peak concentration (Tmax): No significant difference
This means gabapentin does not interfere with how your body processes lithium, and lithium levels remain stable when gabapentin is added.
FDA Labeling Considerations
The FDA labels for both medications do not list each other as contraindicated combinations 1, 2:
- Lithium's FDA label warns about interactions with diuretics, ACE inhibitors, NSAIDs, and antipsychotics (particularly haloperidol), but does not mention gabapentin as problematic 1
- Gabapentin's FDA label notes it has "few drug interactions" and does not list lithium as a concern 4, 2
Important Monitoring Considerations
While the combination is safe, you should be aware of:
Overlapping Side Effects to Monitor
Both medications can cause:
- Dizziness and drowsiness - may be additive when combined 2
- Tremor - both can cause this independently
- Coordination problems - avoid driving or operating machinery until you know how the combination affects you 2
Lithium-Specific Monitoring Remains Essential
Continue standard lithium monitoring regardless of gabapentin use 1:
- Maintain adequate fluid intake (2500-3000 mL daily)
- Maintain normal salt intake
- Watch for lithium toxicity signs: diarrhea, vomiting, tremor, drowsiness, muscle weakness
- Regular lithium level checks as prescribed
Renal Function Consideration
Both medications are renally excreted 1, 2, 3. If you have kidney impairment:
- Gabapentin requires dose reduction based on creatinine clearance 4
- Lithium clearance is also affected by kidney function 1
- Your healthcare provider should adjust doses accordingly
Clinical Context for Short-Term Use
The evidence specifically supports short-term combination use:
- For acute mania: One controlled trial showed adjunctive gabapentin (900 mg/day) with lithium significantly improved mania symptoms over 6 weeks 5
- Gabapentin is typically used short-term for conditions like neuropathic pain, with titration periods of 3-8 weeks 4
Important Caveats
What This Combination Does NOT Address
- Gabapentin has limited efficacy as monotherapy for bipolar disorder - one large placebo-controlled trial found gabapentin ineffective as adjunctive treatment for bipolar disorder, with placebo actually performing better 6
- Suicidality concern: One retrospective study found gabapentin associated with doubled risk of suicidality compared to lithium in bipolar patients 7, though this may reflect underlying illness severity rather than drug effect
Avoid Concurrent CNS Depressants
The 2019 Beers Criteria warns against combining multiple CNS-active agents (including gabapentin) with increased fall risk 8. If you're taking benzodiazepines, opioids, or other sedating medications, discuss this with your prescriber as the combination increases risks.
Practical Recommendations
Start gabapentin at low doses and titrate slowly (100-300 mg at bedtime initially) to minimize additive sedation and dizziness 4. Take gabapentin at least 2 hours apart from antacids containing aluminum or magnesium 2.
Do not stop either medication abruptly - both require gradual discontinuation to avoid withdrawal effects 2.
Contact your healthcare provider immediately if you develop signs of lithium toxicity (even if lithium levels were previously stable), severe drowsiness, coordination problems, or mood changes including suicidal thoughts 1, 2.